Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effectsLu Xu, Han Liu, Yang Zhang et al.|Journal of Experimental & Clinical Cancer Research|2018Cited by 176
Chimeric antigen receptor-modified T Cells inhibit the growth and metastases of established tissue factor-positive tumors in NOG miceQing Zhang, Junnian Zheng, Haiyu Wang et al.|Oncotarget|2016Cited by 24
Chimeric antigen receptor-T cell therapy for solid tumors require new clinical regimensJǐnjīng Xǔ, Junnian Zheng, Haixu Zhang et al.|Expert Review of Anticancer Therapy|2017Cited by 22
Current status and future prospects of the strategy of combining CAR‑T with PD‑1 blockade for antitumor therapy (Review)Jǐnjīng Xǔ, Junnian Zheng, Qing Zhang et al.|Molecular Medicine Reports|2017Cited by 18